Identification of cystatin B in human esophageal carcinoma, using differential displays in which the gene expression is related to lymph-node metastasis

International Journal of Cancer

Volumn 79, Issue 2, 1998, Pages 175-178

  Shiraishi, Takeshi ^a   Mori, Masaki ^a   Tanaka, Shinji ^a   Sugimachi, Keizo ^b   Akiyoshi, Tsuyoshi ^a  

^a KYUSHU UNIVERSITY   (Japan)

^b KYUSHU UNIVERSITY   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

CATHEPSIN; CYSTATIN;

ARTICLE; ENZYME INHIBITION; ESOPHAGUS CANCER; GENE EXPRESSION; GENE SEQUENCE; GENETIC RISK; HUMAN; HUMAN TISSUE; LYMPH NODE METASTASIS; PRIORITY JOURNAL; QUANTITATIVE DIAGNOSIS; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION;

CATHEPSINS; CYSTATINS; CYSTEINE ENDOPEPTIDASES; CYSTEINE PROTEINASE INHIBITORS; ENDOPEPTIDASES; ESOPHAGEAL NEOPLASMS; HUMANS; IMMUNOHISTOCHEMISTRY; LYMPHATIC METASTASIS; POLYMERASE CHAIN REACTION; PREDICTIVE VALUE OF TESTS; PROGNOSIS; RNA, MESSENGER; TRANSCRIPTION, GENETIC;

EID: 0031944913     PISSN: 00207136     EISSN: None     Source Type: Journal    
DOI: 10.1002/(SICI)1097-0215(19980417)79:2<175::AID-IJC13>3.0.CO;2-9     Document Type: Article

References (25)

1. CALLARD, D., LESCURE, B. and MAZZOLINI, L., A method for the elimination of false positives generated by the mRNA differential-display technique. Biotechniques, 16, 1096-1097 (1994).
2. CHAUHAN, S.S., GOLDSTEIN, L.J. and GOTTESMAN, M.M., Expression of cathepsin L in human tumors. Cancer Res., 51, 1478-81 (1991).
3. EBERT, E., WERLE, B., JULKE, B., KOPITAR-JERALA, N., KOS, J., LAQH, T., ABRAHAMSON, M., SPIESS, E. and EBERT, W., Expression of cysteine- protease inhibitors stefin A, stefin B and cystatin C in human lung-tumor tissue. In: Ansorge, S., and Langner, J. (eds.), Cellular peptidases in immune functions and diseases. pp. 259-265, Plenum Press, New York (1997).
4. ITO, T., KITO, K., ADATI, N., MITSUI, Y., HAGIWARA, H. and SAKAKI, Y., Fluorescent differential display: arbitrarily primed RT-PCR fingerprinting on an automated DNA sequencer. FEBS Lett., 351, 231-236 (1994).
5. KASTELIC, L., TURK, B., KOPITAR, J.N., STOLFA, A., RAINER, S., TURK, V. and LAH, T.T., Stefin B, the major low-molecular-weight inhibitor in ovarian carcinoma. Cancer Lett., 82, 81-88 (1994).
6. KATUNUMA, N., Mechanisms and regulation of lysosomal proteolysis. Rev. Sobre Biologia Celular, 20, 35-61 (1989).
7. KNOCH, H., WERLE, B., EBERT, W. and SPIESS, E., Imbalance between cathepsin B and cysteine-proteinase inhibitors is of prognostic significance in human lung cancer. Int. J. Oncol., 5, 77-85 (1994).
8. KOS, J., SMID, A., KRASOVEC, M., SVETIC, B., LENARCIC, B., VRHOVEC, I., SKRK, J. and TURK, V., Lysosomal proteases cathepsins D, B, H, L and their inhibitors stefins A and B in head-and-neck cancer. Biol. Chem. Hoppe-Seyler, 376, 401-405, (1995).
9. KYLLONEN, A.P., JARVINEN, M., HOPSU, H.V., DORN, A., RASANEN, O., LARMI, T. and RINNE, A., The small character behavior of small molecular cysteine-proteinase inhibitors in lung cancers and in surrounding tissue. Acta Histochem., 74, 109-113 (1984).
10. LAH, T.T., KOKALJ, K.M., DROBNIC, K.M., BABNIK, J., GOLOUH, R., VRHOVEC, I. and TURK, V., Cystatins and cathepsins in breast carcinoma. Biol. Chem. Hoppe-Seyler, 373, 595-604 (1992a).
11. LAH, T.T., KOKALJ, K.M., STRUKELJ, B., PUNGERCAR, J., BARLIC, M.D., DROBNIC, K.M., KASTELIC, L., BABNIK, J., GOLOUH, R. and TURK, V., Stefins and lysosomal cathepsins B, L and D in human breast carcinoma. Int. J. Cancer, 50, 36-44 (1992b).
12. LIANG, P. and PARDEE, A.B., Differential display of eukaryotic messenger RNA by means of the polymerase chain reaction. Science, 257, 967-971 (1992).
13. LIANG, P. and PARDEE, A.B., Recent advances in differential display. Curr. Opin. Immunol., 7, 274-280 (1995).
14. MORI, M., BARNARD, G.F., MIMORI, K., UEO, H., AKIYOSHI ,T. and SUGIMACHI, K., Over-expression of matrix metalloproteinase-7 mRNA in human colon carcinomas. Cancer, 75, 1516-1519 (1995a).
15. MORI, M., BARNARD, G.F., STANIUNAS, R.J., JESSUP, J.M., STEELE, G.J. and CHEN, L.B., Prothymosin-alpha mRNA expression correlates with that of c-myc in human colon cancer. Oncogene, 8, 2821-6 (1993).
16. MORI, M., MIMORI, K., INOUE, H., BARNARD, G.F., TSUJI, K., NANBARA, S., UEO, H. and AKIYOSHI, T., Detection of cancer micrometastasis in lymph nodes by reverse transcriptase-polymerase chain reaction. Cancer Res., 55, 3417-3420 (1995b).
17. MORI, M., MIMORI, K., SHIRAISHI, T., TANAKA, S., UEO, H., SUGIMACHI, K. and AKIYOSHI, T., p27 expression and gastric carcinoma. Nature Med., 3, 593 (1997).
18. NAVAB, R., MORT, J.S. and BRODT, P., Inhibition of carcinoma-cell invasion and liver metastases formation by the cysteine-proteinase inhibitor E-64. Clin. exp. Metastasis, 15, 121-129 (1997).
19. PLEBANI, M., HERSZENYI, L., CARDIN, R., ROVERONI, G., CARRARO, P., PAOLI, M.D., RUGGE, M., GRIGIONI, W.F., NITTI, D., NACCARATO, R. and FARINATI, F., Cysteine and serine proteases in gastric cancer. Cancer, 76, 367-375 (1995).
20. SHEAHAN, K., SHUJA, S. and MURNANE, M.J., Cysteine-protease activities and tumor development in human colorectal carcinoma. Cancer Res., 49, 3809-3814 (1989).
21. SHUJA, S. and MURNANE, M.J., Marked increases in cathepsin B and L activities distinguish papillary carcinoma of the thyroid from normal thyroid or thyroid with non-neoplastic disease. Int. J. Cancer, 66, 420-426 (1996).
22. SHUJA, S., SHEAHAN, K. and MURNANE, M.J., Cysteine-ondopeptidase activity levels in normal human tissues, colorectal adenomas and carcinomas. Int. J. Cancer, 49, 341-346 (1991).
23. TURK, V. and BODE, W., The cystatins: protein inhibitors of cysteine proteinases. FEBS Lett. 285, 213-219 (1991).
24. WHRLE, B., EBERT, W., KLEIN, W. and SPIESS, E., Assessment of cathepsin-L activity by use of the inhibitor CA-074 compared to cathepsin-B activity in human lung-tumor tissue. Biol. Chem. Hoppe-Seyler; 376, 157-164 (1995).
25. ZHAO, S., OOI, S.L. and PARDEE, A.B., New primer strategy improves precision of differential display. Biotechniques, 18, 842-846 (1995).